-
NIH Funds Biosensors to Monitor Oxygen in Tissue
11 April 2016. Profusa Inc., a company designing sensors that measure tissue oxygen levels in individuals with peripheral artery disease, received an NIH grant to advance its technology. The $225,000 Small Business Innovation Research grant for 2016 is divided between two agencies of National Institutes of Health: National Center for Advancing Translational Sciences and National…
-
Flair4IT Helps Cloud Computing Become Mainstream in the EU
– Sponsored Content – 11 April 2016. Flair4IT, a UK based IT agency, has been working on making the cloud more mainstream in the EU. They have looked specifically at software applications and infrastructures. To enable the market to become more aware of cloud computing, and to make it as common as what it is…
-
Smartphone-Based Sensor Gives Early Epilepsy Warning
8 April 2016. An academic and business consortium in Germany is developing a small sensor worn in the ear that detects and warns of seizures in people with epilepsy. The 3-year Epitect project to develop the system, including smartphone software and cloud-based analytics, is led by University Hospital Bonn and supported with €2 million ($US…
-
Start-Up Licensing Biologic Delivery Nanoparticles
8 April 2016. A start-up enterprise is licensing research from a university pharmacy lab that harnesses nanoscale particles to boost the performance of biologic therapies. Financial details of the agreement between Zoetic Pharmaceuticals in Amherst, New York and University at Buffalo were not disclosed. Biologic therapies are synthetic proteins derived from living systems, such as…
-
Cancer Centers, Analytics, Pharma Plan Precision Medicine
7 April 2016. A cancer care center network, with pharmaceutical and informatics companies, plan to apply precision medicine techniques to increase the pool of patients for clinical trials of new cancer therapies. The coalition includes cancer centers in the Orien network — short for Oncology Research Information Exchange Network — with bioinformatics company M2Gen, and…
-
Trial Shows Pain Drug Effective as Heroin Treatment
7 April 2016. A clinical trial in Canada shows a drug already in use for chronic pain can serve as a substitute maintenance treatment for people addicted to heroin. The findings of the trial, conducted by University of British Columbia in Vancouver and other institutions in Canada, appear 6 April in the journal JAMA Psychiatry.…
-
$500K Challenge Seeks Mood Research Ideas with iPhone
Update, 20 July 2016. The Robert Wood Johnson Foundation sponsoring the Mood Challenge announced the competition’s 5 semi-finalists: – Aware Study, to measure mood and posttraumatic stress symptoms among the millions of adults living with PTSD. – BiAffect, a system for understanding mood and neurocognitive functioning in bipolar disorder using keystroke dynamics, such as typing…
-
Stem Cell Biotech Licensing Blood Vessel Repair Technology
6 April 2016. Cellular Dynamics International, a developer of regenerative treatments from stem cells, is licensing university research that repairs blood vessels in people with peripheral artery disease. Financial aspects of the deal between Indiana University and Cellular Dynamics, a subsidiary of FujiFilm in Madison, Wisconsin, were not disclosed. Cellular Dynamics designs and generates induced…
-
Study to Test Increasing Ethnic Genetic Disease Diversity
5 April 2016. The personal genetics company 23andMe is beginning a study to test techniques for increasing the diversity of disease-causing genetic variations, which now overwhelmingly favor Europeans. The study is funded by a $260,000 Small Business Innovation Research grant from National Institutes of Health. The study aims to provide better tools for genetics researchers…
-
Stem Cells Shown to Improve Heart Failure Health Outcomes
5 April 2016. Results from a clinical trial show a new therapy for heart failure using patients’ own blood-forming stem cells reduces worsening symptoms, hospitalizations, and deaths. Findings of the study testing the treatments developed by biopharmaceutical company Vericel Corp., which funded the trial, appear in today’s issue of the journal The Lancet (paid subscription…